Corneal Cross-Linking Window Absorption (CXL-WA) as an Adjuvant Therapy in the Management of<i> Aspergillus niger</i> Keratitis

<div>Anterior segment photography and AS-OCT showing a central 2x2 mm descemetocele with a thinning of the cornea (232 <i>μ</i>m centrally and 116 <i>μ</i>m peripherally).</div>

Case Reports in Ophthalmological Medicine

fig3

Figure 3

Figure 3: Corneal Cross-Linking Window Absorption (CXL-WA) as an Adjuvant Therapy in the Management of<i> Aspergillus niger</i> Keratitis 

Case Reports in Ophthalmological Medicine

Corneal Cross-Linking Window Absorption (CXL-WA) as an Adjuvant Therapy in the Management of Aspergillus niger Keratitis

Figure 3